MRSH
Bearish signalScored 2026-10-19 Drivers: Congress, trend, fundamentals. Insiders: neutral. Moteurs : Congrès, tendance, fondamentaux. Initiés : neutre.
Research, not advice.
À propos
Marsh & McLennan Companies, Inc.
- Nom
- Marsh & McLennan Companies, Inc.
- Secteur
- Financial Services
- Industrie
- Insurance - Brokers
- Bourse
- NYSE
- Capitalisation
- $94.2B
- Employés
- 95,000
- PDG
- John Q. Doyle
- Site web
- http://www.corporate.marsh.com
- Marché
- AJGAONBROBWINRYANWTW
Marsh & McLennan Companies, Inc. (MRSH) functions as a leading professional services organization, delivering expert guidance and innovative solutions to clients across the vital domains of risk management, strategic planning, and human capital. Based in New York City, the firm maintains a substantial global workforce, employing approximately 65,000 full-time professionals. This entity serves as the parent company for several prominent advisory and consulting brands. These include Marsh, renowned for its insurance brokerage services; Guy Carpenter, a specialist in risk and reinsurance; Mercer, which provides comprehensive human resources and investment-related financial advice; and Oliver Wyman Group, an influential management and economic consultancy. Marsh & McLennan structures its operations into two core business segments. The "Risk and Insurance Services" division encompasses activities such as risk management, along with comprehensive insurance and reinsurance brokerage and services. The "Consulting" division offers a broad spectrum of services, including health, retirement, talent, and investment consulting, as well as specialized advice in management, economics, and brand strategy. The Risk and Insurance Services segment's operations are primarily conducted through Marsh and Guy Carpenter, while Mercer and Oliver Wyman Group are the key contributors to the Consulting segment's offerings.
Price (1 year)
Live chart from TradingView — independent market data, as price context around the filings, not the Quorum score. EMA 50/200 and Bollinger load by default. When the exchange is known it is sent as EXCHANGE:SYMBOL; otherwise TradingView resolves the ticker best-effort.
VENTE TOTALE: 12 000 titres (~2 107 800,00 $ US)
- Insiders
- Yates Lloyd M
- Total bought
-
—
Avg buy (VWAP, 90d window) —
- Total sold
-
$6,102,582
Avg sell (VWAP, 90d window) $189.72 vs last close $188.50 (-0.6%)
Total sold sums Form 4 code S in this window. Codes F, M, A and G are left out.
$3,280,997 of that total is under a Rule 10b5-1 plan. It is shown here and left out of the score.
- Last activity
- 2026-07-23
- Liquidity
- Liquid $533,031,648/day · 20d vol
- Last synced
-
2026-10-19 21:57:14
Sign in to request a sync of this company's price history and timing levels.
Insider holdings as a share of total assets aren't available for this company.
Avg buy and avg sell are volume-weighted prices (sum of shares × price, divided by shares) for Form 4 rows in this 90-day window that report both figures. A comparison with last close is market context for that average, not advice.
Recent Form 4
Filings in the 90-day window for this company. Value is shares × price from the filing. Research, not advice.
| Date | Person | Side | Shares | Price | Value | Form 4 |
|---|---|---|---|---|---|---|
| 2026-09-02 | Brennan Katherine | Sell · S | 1,197 | $187.90 | $224,915 | Form 4 |
| 2026-09-02 | Doyle John Q | Sell · S · 10b5-1 | 16,656 | $188.51 | $3,139,823 | Form 4 |
| 2026-08-06 | Jones John Jude | Sell · S | 6,500 | $191.96 | $1,247,723 | Form 4 |
| 2026-07-29 | Beswick Paul | Sell · S · 10b5-1 | 713 | $198.00 | $141,174 | Form 4 |
| 2026-07-28 | South Martin | Sell · S | 7,100 | $189.99 | $1,348,947 | Form 4 |
Sales marked 10b5-1 are scheduled in advance and don't count toward the Quorum score. Les ventes marquées 10b5-1 sont planifiées à l'avance et ne pèsent pas dans le score Quorum.
Congressional trades
STOCK Act disclosures (90-day window)
Amounts are STOCK Act brackets as disclosed. Quorum does not turn a bracket into an exact price or a midpoint.
No STOCK Act disclosures for this company in this window.
Recent trades
| Date | Representative | Type | Amount |
|---|---|---|---|
| 2026-09-23 | Kevin Hern | Sale (Full) | $50,001 - $100,000 |
| 2026-09-17 | Kevin Hern | Sale (Partial) | $50,001 - $100,000 |
| 2026-09-14 | Kevin Hern | Sale (Partial) | $1,001 - $15,000 |
| 2026-09-09 | Kevin Hern | Sale (Partial) | $100,001 - $250,000 |
| 2026-09-02 | Kevin Hern | Sale (Partial) | $1,001 - $15,000 |
| 2026-08-24 | Kevin Hern | Sale (Full) | $1,001 - $15,000 |
| 2026-06-02 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2026-05-01 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2026-04-13 | Ro Khanna | Purchase | $1,001 - $15,000 |
| 2026-01-29 | Ro Khanna | Sale | $1,001 - $15,000 |
| 2026-01-13 | Ro Khanna | Purchase | $15,001 - $50,000 |
Signal
Bearish signalScored 2026-10-19 Drivers: Congress, trend, fundamentals. Insiders: neutral. Moteurs : Congrès, tendance, fondamentaux. Initiés : neutre.
MRSH presents a mixed picture: solid profitability and free cash flow generation are offset by a dangerously overbought RSI (88.5), tightening margins, and a weak catalyst score of 25 driven by a post-earnings analyst…
The first sentence of the analysis written for MRSH on 2026-10-19 - a real excerpt, not a sample. The rest of it, the 0-100 score and the rating it produced are part of Plus. See plans.
Factor checklist — research, not advice
A check leans with a bullish reading. A cross leans against it. A dash is unavailable or mixed.
- Insider Unavailable or mixed. No open-market purchase or sale value stored
- Narrative Unavailable or mixed. Stored narrative reading is in the neutral band
- Congress Pulls against a bullish reading. STOCK Act sale disclosures outnumber purchases
- Timing Supports a bullish reading. Interesting trend — weekly bias up
- Financial indicators Supports a bullish reading. Current ratio 1.10 · operating margin 23%
Suggested stop 184.63, nearest stored support minus 0.5 ATR(2.0% under the last close). Reward/risk to the next stored resistance is 1.25. Wait — that reward/risk is under 2. Research, not advice. Not an order.
Recent news
- 2026-10-19 Marsh & McLennan: 3 Key Takeaways for Long-Term Investors Management raised its Thrive program savings target to $600 million. London wholesale digital trading reached 93% using new workbench tools.
- 2026-10-19 Frank Rimerman Advisors LLC Acquires 3,010 Shares of Marsh & McLennan Companies, Inc. $MRSH Frank Rimerman Advisors LLC increased its holdings in Marsh and McLennan Companies, Inc. (NYSE: MRSH) by 96.6% in the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 6,125 shares of the financial services provider''s stock after acquiring an additional
- 2026-10-18 Marsh & McLennan Companies, Inc. $MRSH Holdings Decreased by Birch Hill Investment Advisors LLC Birch Hill Investment Advisors LLC lowered its stake in Marsh and McLennan Companies, Inc. (NYSE: MRSH) by 3.9% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 394,139 shares of the financial services provider''s stock after selling 16,094 shares during the
- 2026-10-17 Marsh & McLennan Companies, Inc. $MRSH Shares Sold by Banque Pictet & Cie SA Banque Pictet and Cie SA cut its holdings in Marsh and McLennan Companies, Inc. (NYSE: MRSH) by 24.0% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 96,433 shares of the financial services provider''s stock after selling 30,421 shares during the
- 2026-10-16 Marsh & McLennan: Challenging Operating Environment Likely To Persist Ahead Marsh & McLennan faces cyclical headwinds and margin pressure, prompting a downgrade to ''Hold'' despite solid execution and strategic initiatives. Q3 2026 saw MRSH beat revenue and EPS estimates, but underlying growth slowed as P&C pricing trends and reinsurance weakness weighed on results. Cost-cutting targets were raised to $600 million by 2028, but inflation and wage pressures continue to erode operating margins, now at 17.7%.
- 2026-10-15 Marsh Q3 Earnings Beat Estimates on Consulting Growth Despite Higher Costs Marsh''s Q3 2026 earnings beat estimates as strong growth in Consulting and Risk and Insurance Services lifted revenues, despite rising operating expenses.
- 2026-10-15 Marsh & McLennan Companies, Inc. (MRSH) Q3 2026 Earnings Call Transcript Marsh & McLennan Companies, Inc. (MRSH) Q3 2026 Earnings Call Transcript
- 2026-10-15 Marsh & McLennan Companies Q3 Earnings Call Highlights Marsh & McLennan Companies NYSE: MRSH reported third-quarter revenue growth and double-digit adjusted earnings-per-share growth, while increasing the savings target for its Thrive efficiency program and outlining additional investments in artificial intelligence, sales capacity and client services.
- 2026-10-15 Marsh (MRSH) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates The headline numbers for Marsh (MRSH) give insight into how the company performed in the quarter ended September 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
- 2026-10-15 Marsh (MRSH) Q3 Earnings and Revenues Beat Estimates Marsh (MRSH) came out with quarterly earnings of $2.03 per share, beating the Zacks Consensus Estimate of $1.96 per share. This compares to earnings of $1.85 per share a year ago.
Market snapshot
Financial ratios
| Metric | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|---|
| Gross Profit Margin | 42.3% | 42.8% | 42.4% | 41.7% | 42.4% | |
| Ebit Margin | 24.0% | 25.3% | 24.6% | 22.0% | 23.5% | |
| Ebitda Margin | 27.4% | 28.3% | 27.8% | 25.4% | 27.2% | |
| Operating Profit Margin | 23.1% | 23.8% | 23.2% | 20.7% | 21.8% | |
| Pretax Profit Margin | 20.5% | 22.4% | 22.1% | 19.7% | 21.2% | |
| Continuous Operations Profit Margin | 15.7% | 16.8% | 16.7% | 14.9% | 16.0% | |
| Net Profit Margin | 15.4% | 16.6% | 16.5% | 14.7% | 15.9% | |
| Bottom Line Profit Margin | 15.4% | 16.6% | 16.5% | 14.7% | 15.9% | |
| Current Ratio | 1.102 | 1.133 | 1.099 | 1.063 | 1.242 | |
| Quick Ratio | 1.102 | 1.133 | 1.099 | 1.063 | 1.242 | |
| Solvency Ratio | 0.117 | 0.112 | 0.125 | 0.113 | 0.168 | |
| Cash Ratio | 0.128 | 0.123 | 0.170 | 0.081 | 0.263 | |
| Price To Earnings Ratio | 21.877 | 25.747 | 24.930 | 27.083 | 28.035 | |
| Price To Earnings Growth Ratio | 7.847 | 3.010 | 1.022 | -18.658 | 0.503 | |
| Forward Price To Earnings Growth Ratio | 7.847 | 3.010 | 1.022 | -18.658 | 0.503 | |
| Price To Earnings Diluted Ratio | 22.007 | 25.967 | 25.162 | 27.397 | 28.356 | |
| Price To Earnings Diluted Growth Ratio | 7.201 | 3.008 | 1.020 | -18.661 | 0.510 | |
| Price To Book Ratio | 5.983 | 7.833 | 7.678 | 7.849 | 8.005 | |
| Price To Sales Ratio | 3.349 | 4.273 | 4.117 | 3.985 | 4.446 | |
| Price To Free Cash Flow Ratio | 18.066 | 26.218 | 24.362 | 27.571 | 28.337 | |
| Price To Operating Cash Flow Ratio | 17.073 | 24.292 | 21.982 | 23.831 | 25.064 | |
| Debt To Assets Ratio | 0.365 | 0.387 | 0.321 | 0.305 | 0.383 | |
| Debt To Equity Ratio | 1.420 | 1.639 | 1.266 | 1.281 | 1.196 | |
| Debt To Capital Ratio | 0.587 | 0.621 | 0.559 | 0.562 | 0.545 | |
| Long Term Debt To Capital Ratio | 0.548 | 0.593 | 0.493 | 0.516 | 0.498 | |
| Financial Leverage Ratio | 3.888 | 4.233 | 3.940 | 4.193 | 3.124 | |
| Working Capital Turnover Ratio | 11.387 | 10.746 | 14.764 | 15.141 | 12.505 | |
| Operating Cash Flow Ratio | 0.251 | 0.220 | 0.215 | 0.194 | 0.528 | |
| Operating Cash Flow Sales Ratio | 0.196 | 0.176 | 0.187 | 0.167 | 0.177 | |
| Free Cash Flow Operating Cash Flow Ratio | 0.945 | 0.927 | 0.902 | 0.864 | 0.885 | |
| Debt Service Coverage Ratio | 2.735 | 4.564 | 2.318 | 5.801 | 9.469 | |
| Interest Coverage Ratio | 6.482 | 8.310 | 9.138 | 9.126 | 9.712 | |
| Short Term Operating Cash Flow Coverage Ratio | 4.177 | 8.289 | 2.630 | 12.929 | 206.824 | |
| Operating Cash Flow Coverage Ratio | 0.247 | 0.197 | 0.276 | 0.257 | 0.267 | |
| Capital Expenditure Coverage Ratio | 18.186 | 13.614 | 10.236 | 7.372 | 8.660 | |
| Dividend Paid And Capex Coverage Ratio | 2.659 | 2.352 | 2.484 | 2.155 | 2.455 | |
| Dividend Payout Ratio | 0.408 | 0.373 | 0.346 | 0.373 | 0.326 | |
| Enterprise Value Multiple | 14.755 | 17.899 | 16.729 | 17.952 | 18.436 |
Sparkline shows each ratio oldest → newest (left → right).
How the latest year compares
For each ratio: its most recent value, the change versus one year earlier, and versus its 5-year average. ▲ higher ▼ lower
| Metric | Current | vs 1Y ago | vs 5Y avg |
|---|---|---|---|
| Gross Profit Margin | 42.3% | ▼-0.5% | ▼-0.0% |
| Ebit Margin | 24.0% | ▼-1.2% | ▲0.2% |
| Ebitda Margin | 27.4% | ▼-0.9% | ▲0.2% |
| Operating Profit Margin | 23.1% | ▼-0.7% | ▲0.6% |
| Pretax Profit Margin | 20.5% | ▼-1.9% | ▼-0.7% |
| Continuous Operations Profit Margin | 15.7% | ▼-1.1% | ▼-0.3% |
| Net Profit Margin | 15.4% | ▼-1.2% | ▼-0.4% |
| Bottom Line Profit Margin | 15.4% | ▼-1.2% | ▼-0.4% |
| Current Ratio | 1.102 | ▼-0.032 | ▼-0.026 |
| Quick Ratio | 1.102 | ▼-0.032 | ▼-0.026 |
| Solvency Ratio | 0.117 | ▲0.005 | ▼-0.010 |
| Cash Ratio | 0.128 | ▲0.005 | ▼-0.025 |
| Price To Earnings Ratio | 21.877 | ▼-3.869 | ▼-3.657 |
| Price To Earnings Growth Ratio | 7.847 | ▲4.837 | ▲9.102 |
| Forward Price To Earnings Growth Ratio | 7.847 | ▲4.837 | ▲9.102 |
| Price To Earnings Diluted Ratio | 22.007 | ▼-3.960 | ▼-3.771 |
| Price To Earnings Diluted Growth Ratio | 7.201 | ▲4.193 | ▲8.585 |
| Price To Book Ratio | 5.983 | ▼-1.849 | ▼-1.486 |
| Price To Sales Ratio | 3.349 | ▼-0.924 | ▼-0.685 |
| Price To Free Cash Flow Ratio | 18.066 | ▼-8.152 | ▼-6.845 |
| Price To Operating Cash Flow Ratio | 17.073 | ▼-7.220 | ▼-5.376 |
| Debt To Assets Ratio | 0.365 | ▼-0.022 | ▲0.013 |
| Debt To Equity Ratio | 1.421 | ▼-0.218 | ▲0.060 |
| Debt To Capital Ratio | 0.587 | ▼-0.034 | ▲0.012 |
| Long Term Debt To Capital Ratio | 0.548 | ▼-0.045 | ▲0.018 |
| Financial Leverage Ratio | 3.888 | ▼-0.345 | ▲0.012 |
| Working Capital Turnover Ratio | 11.387 | ▲0.641 | ▼-1.522 |
| Operating Cash Flow Ratio | 0.251 | ▲0.031 | ▼-0.031 |
| Operating Cash Flow Sales Ratio | 0.196 | ▲0.020 | ▲0.015 |
| Free Cash Flow Operating Cash Flow Ratio | 0.945 | ▲0.018 | ▲0.041 |
| Debt Service Coverage Ratio | 2.735 | ▼-1.829 | ▼-2.243 |
| Interest Coverage Ratio | 6.482 | ▼-1.828 | ▼-2.071 |
| Short Term Operating Cash Flow Coverage Ratio | 4.177 | ▼-4.112 | ▼-42.793 |
| Operating Cash Flow Coverage Ratio | 0.247 | ▲0.050 | ▼-0.002 |
| Capital Expenditure Coverage Ratio | 18.186 | ▲4.572 | ▲6.572 |
| Dividend Paid And Capex Coverage Ratio | 2.659 | ▲0.307 | ▲0.238 |
| Dividend Payout Ratio | 0.408 | ▲0.036 | ▲0.043 |
| Enterprise Value Multiple | 14.755 | ▼-3.145 | ▼-2.400 |
Key metrics
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Market cap | $90.35B | $104.51B | $93.60B | $82.57B | $88.13B | |
| Enterprise value | $109.11B | $123.97B | $105.68B | $94.60B | $99.54B | |
| EV / Sales | 4.04x | 5.07x | 4.65x | 4.57x | 5.02x | |
| EV / Op. cash flow | 20.62x | 28.82x | 24.82x | 27.30x | 28.31x | |
| EV / Free cash flow | 21.82x | 31.10x | 27.51x | 31.59x | 32.01x | |
| EV / EBITDA | 14.76x | 17.90x | 16.73x | 17.95x | 18.44x | |
| Net debt / EBITDA | 2.54x | 2.81x | 1.91x | 2.28x | 2.11x | |
| Current ratio | 1.10x | 1.13x | 1.10x | 1.06x | 1.24x | |
| Income quality | 1.25x | 1.06x | 1.12x | 1.12x | 1.11x | |
| Graham number | $77 | $71 | $65 | $54 | $55 | |
| Graham net-net | -$72 | -$72 | -$56 | -$55 | -$34 | |
| Tax burden | 75.1% | 74.1% | 74.7% | 74.7% | 74.7% | |
| Interest burden | 85.4% | 88.7% | 89.7% | 89.7% | 90.5% | |
| Working capital | $2.14B | $2.60B | $1.95B | $1.13B | $1.61B | |
| Invested capital | $33.98B | $33.08B | $24.24B | $22.84B | $23.45B | |
| Return on assets | 7.1% | 7.2% | 7.8% | 6.9% | 9.1% | |
| Operating ROA | 10.8% | 11.1% | 11.5% | 10.9% | 12.8% | |
| Return on tangible assets | 14.3% | 14.3% | 13.3% | 12.3% | 20.6% | |
| Return on equity | 27.5% | 30.4% | 30.8% | 29.0% | 28.5% | |
| Return on invested capital | 12.1% | 11.6% | 13.2% | 12.1% | 11.6% | |
| Return on capital employed | 16.5% | 15.7% | 18.7% | 16.3% | 15.5% | |
| Earnings yield | 4.6% | 3.9% | 4.0% | 3.7% | 3.6% | |
| Free cash flow yield | 5.5% | 3.8% | 4.1% | 3.6% | 3.5% | |
| Capex / Op. cash flow | 5.5% | 7.3% | 9.8% | 13.6% | 11.5% | |
| Capex / Depreciation | 32.0% | 42.4% | 58.3% | 65.4% | 54.4% | |
| Capex / Sales | 1.1% | 1.3% | 1.8% | 2.3% | 2.0% | |
| SG&A / Sales | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| R&D / Sales | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| Stock comp / Sales | 1.5% | 1.5% | 1.6% | 1.8% | 1.8% | |
| Intangibles / Total assets | 50.3% | 49.8% | 41.4% | 43.7% | 55.6% | |
| Days sales outstanding | 104d | 107d | 103d | 103d | 103d | |
| Days payables outstanding | 86d | 89d | 95d | 99d | 101d | |
| Operating cycle | 104d | 107d | 103d | 103d | 103d | |
| Cash conversion cycle | 18d | 18d | 8d | 4d | 2d |
Change by theme
Grouped by what each metric measures. Each figure is the change over the period shown — ▲ up ▼ down versus then.
Change over 1 year
Change over 5 years